Antitumor activity of IDN 5109, a new taxane, on human ovarian carcinoma xenografts

被引：0
|
作者：
Rossi, C
Mincione, T
Nicoletti, I
Bombardelli, E
Riva, A
Donati, MB
Giavazzi, R
机构：
[1] Consorzio Mario Negri Sud, Chieti, Italy
[2] Mario Negri Inst Pharmacol Res, I-24100 Bergamo, Italy
[3] Indena SPA, I-20141 Milan, Italy
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
349
引用
收藏
页码：92 / 92
页数：1
相关论文
共 50 条
  • [1] IDN5109, a new taxane with oral bioavailability and antitumor activity.
    Nicoletti, MI
    Colombo, T
    Monardo, C
    Rossi, C
    Zucchetti, M
    Bombardelli, E
    Riva, A
    D'Incalci, M
    Giavazzi, R
    CLINICAL CANCER RESEARCH, 1999, 5 : 3855S - 3855S
  • [2] IDN5109, a taxane with oral bioavailability and potent antitumor activity
    Nicoletti, MI
    Colombo, T
    Rossi, C
    Monardo, C
    Stura, S
    Zucchetti, M
    Riva, A
    Morazzoni, P
    Donati, MB
    Bombardelli, E
    D'Incalci, M
    Giavazzi, R
    CANCER RESEARCH, 2000, 60 (04) : 842 - 846
  • [3] IDN5109: A new taxane with a broad spectrum of activity
    Polizzi, D
    Pratesi, G
    Perego, P
    Tortoreto, M
    Bombardelli, E
    Riva, A
    Zunino, F
    ANNALS OF ONCOLOGY, 1998, 9 : 94 - 94
  • [4] Antiangiogenic and antitumor activity of IDN 5390, a new taxane derivative
    Taraboletti, G
    Micheletti, G
    Rieppi, M
    Poli, M
    Turatto, M
    Rossi, C
    Borsotti, P
    Roccabianca, P
    Scanziani, E
    Nicoletti, MI
    Bombardelli, E
    Morazzoni, P
    Riva, A
    Giavazzi, R
    CLINICAL CANCER RESEARCH, 2002, 8 (04) : 1182 - 1188
  • [5] Antitumor effects of IDN5109 on head and neck squamous cell carcinoma
    Sano, D
    Matsuda, H
    Ishiguro, Y
    Nishimura, G
    Kawakami, M
    Tsukuda, M
    ONCOLOGY REPORTS, 2006, 15 (02) : 329 - 334
  • [6] Cellular bases of the antitumor activity of the novel taxane IDN 5109 (BAY59-8862) on hormone-refractory prostate cancer
    Cassinelli, G
    Lanzi, C
    Supino, R
    Pratesi, G
    Zuco, V
    Laccabue, D
    Cuccuru, G
    Bombardelli, E
    Zunino, F
    CLINICAL CANCER RESEARCH, 2002, 8 (08) : 2647 - 2654
  • [7] Ecteinascidin-743, a new marine natural product with potent antitumor activity on human ovarian carcinoma xenografts
    Valoti, G
    Nicoletti, MI
    Pellegrino, A
    Jimeno, J
    Hendriks, H
    D'Incalci, M
    Faircloth, G
    Giavazzi, R
    CLINICAL CANCER RESEARCH, 1998, 4 (08) : 1977 - 1983
  • [8] Antitumor activity and biodistribution of cisplatin nanocapsules in nude mice bearing human ovarian carcinoma xenografts
    Staffhorst, Rutger W. H. M.
    van der Born, Kasper
    Erkelens, Caroline A. M.
    Hamelers, Irene H. L.
    Peters, Godefridus J.
    Boven, Epie
    de Kroon, Anton I. P. M.
    ANTI-CANCER DRUGS, 2008, 19 (07) : 721 - 727
  • [9] Antitumor effects of IDN5109 on head and neck squamous cell carcinoma (vol 15, pg 329, 2006)
    Sano, Daisuke
    Matsuda, Hideki
    Ishiguro, Yukari
    Nishimura, Goshi
    Kawakami, Mariko
    Tsukuda, Mamoru
    ONCOLOGY REPORTS, 2016, 35 (04) : 2494 - 2494
  • [10] Antitumor activity of the new aureolic acid derivatives mithramycin SDK and SK in human ovarian cancer xenografts
    Previdi, S.
    Albertini, V.
    Nur-e-Alam, M.
    Kwee, I.
    Broggini, M.
    Carbone, G. M.
    Rohr, J.
    Catapano, C. V.
    EJC SUPPLEMENTS, 2006, 4 (12): : 97 - 97
12345